November 4, 2013

Dollar General on Monday announced a number of senior management changes.

October 30, 2013

A division of inVentiv Health has acquired Catalina Marketing's medication adherence services subsidiary, inVentiv said Thursday.

October 30, 2013

The Paws Pet Co. is buying an Irvine, Calif.-based compounding pharmacy as it seeks to transition from a pet company into a pharmaceutical company, Paws said.

October 29, 2013

Actavis had sales of $2.01 billion in third quarter 2013, a 57% increase over the same period last year, the drug maker said Tuesday.

October 23, 2013

Drug maker Depomed has sold its interests in royalty and milestone payments for several Type 2 diabetes drugs to PDL BioPharma, Depomed said.

October 18, 2013

Francisco Partners, a technology-focused private equity firm, earlier this week signed a definitive agreement to acquire McKesson Automation, a unit of McKesson Corp. that offers integrated pharmacy automation solutions for hospitals and health systems.

October 15, 2013

AstraZeneca has acquired a British developer of biotech drugs for treating cancer, AstraZeneca said Tuesday.

October 10, 2013

Anti-aging products, once the darling of the facial skin care category, have experienced a slowdown in growth since the recession — due, in part, to an influx of new products and likely some cannibalization from such multitasking products as BB creams. Meanwhile, skin care staples like facial moisturizers and cleansers have moved into the lead. And while the overall facial skin care category is projected to see little growth in 2013, industry sources suggest that a turnaround is on the horizon.

October 10, 2013

A subsidiary of Johnson & Johnson has acquired rights to an experimental drug for hepatitis C from GlaxoSmithKline.

October 4, 2013

Giant Food Stores turned 90 Friday, the Ahold USA-owned supermarket chain said.

October 3, 2013

GNC Holdings on Wednesday announced it has acquired A1 Sports Limited (d.b.a. Discount Supplements), a multi-brand sports nutrition e-commerce retailer in the United Kingdom.

September 30, 2013

Amneal Pharmaceuticals has bought rights to four generic drugs from Actavis, Amneal said Monday.

September 10, 2013

Shareholders of Actavis and Warner Chilcott have approved the merger of the two drug makers, the companies said Tuesday.

September 10, 2013

The former CEO of Bausch + Lomb has been appointed president and CEO of Forest Labs, the drug maker said Tuesday.

September 10, 2013

Private investment firm Yucaipa Cos., which was founded by billionaire Ron Burkle, has announced that it plans to acquire Fresh & Easy Neighborhood Market from U.K.-based Tesco PLC.

September 5, 2013

Japanese drug maker Otsuka Pharmaceutical Co. is buying U.S.-based Astex Pharmaceuticals for $886 million, Otsuka said Thursday.

September 4, 2013

IRI announced it has acquired Aztec, a provider of market measurement and related services for consumer packaged goods, liquor and pharmaceutical manufacturers and retailers in Australia, Canada, Hong Kong, New Zealand, South Africa, Sweden and the United Kingdom. Aztec was acquired from Aegis Media.

August 28, 2013

A subsidiary of Endo Health Solutions is buying Boca Pharmacal for $225 million, Endo said Wednesday.

August 26, 2013

Biotech company Amgen is buying Onyx Pharmaceuticals, the companies said Sunday.

August 26, 2013

Former Kinray owner Stewart Rahr has made a large donation to an organization looking for a cure for prostate cancer.

August 8, 2013

Despite significant challenges coming from private label, Procter & Gamble is still attempting to innovate the No. 1 brand in all of digestives — Prilosec OTC.

August 7, 2013

PingMD, a New York City-based mobile communications healthcare solutions company, has announced that Lambda Fund IV is making an investment in PingMD’s B-round of funding.

August 2, 2013

Pharmacy benefit manager Catamaran Corp. had $3.4 billion in revenues in second quarter 2013, the company said.

August 2, 2013

Cereal maker Post Holdings will be playing a larger role in the supplement space with its proposed acquisition of Premier Nutrition, makers of the Joint Juice brand.